Mi, DaZhao
20  results:
Search for persons X
?
1

Discovery of a Highly Potent and Selective MYOF Inhibitor w..:

Gu, Haijun ; Zhang, Ting ; Guan, Tian...
Journal of Medicinal Chemistry.  66 (2023)  24 - p. 16917-16938 , 2023
 
?
4

Discovery of Pyrimidinediamine Derivatives as Potent Methuo..:

He, Jia ; Wang, Luzhen ; Mi, DaZhao...
Journal of Medicinal Chemistry.  66 (2023)  11 - p. 7421-7437 , 2023
 
?
6

Current advances of small molecule E3 ligands for proteolys..:

Mi, Dazhao ; Li, Yuzhan ; Gu, Haijun..
European Journal of Medicinal Chemistry.  256 (2023)  - p. 115444 , 2023
 
?
7

An instructive attempt on developing aptamer-constructed PR..:

Zhang, Yuzhu ; Mi, Dazhao ; Chen, Yihua
Molecular Therapy - Nucleic Acids.  30 (2022)  - p. 351-352 , 2022
 
?
8

B-cell Lymphoma 6 Inhibitors: Current Advances and Prospect..:

Gu, Haijun ; He, Jia ; Li, Yuzhan...
Journal of Medicinal Chemistry.  65 (2022)  23 - p. 15559-15583 , 2022
 
?
9

In vivo target protein degradation induced by PROTACs based..:

Li, Liang ; Mi, Dazhao ; Pei, Haixiang...
Signal Transduction and Targeted Therapy.  5 (2020)  1 - p. , 2020
 
?
10

Modification and Biological Evaluation of a Series of 1,5-D..:

Li, Yunqi ; He, Yuan ; Shao, Ting...
Journal of Medicinal Chemistry.  62 (2019)  10 - p. 4949-4966 , 2019
 
?
 
?
12

In vivo target protein degradation induced by PROTACs based..:

Li, Liang ; Mi, Dazhao ; Pei, Haixiang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383041/.  , 2020
 
1-15